This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change ACBPositive Net Change
earnings medical medical-devices
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change AVNSPositive Net Change
earnings medical medical-devices
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand
by Zacks Equity Research
QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.
BSXPositive Net Change QDELNegative Net Change WSTNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands
by Zacks Equity Research
DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.
BSXPositive Net Change DVAPositive Net Change WSTNegative Net Change GEHCNegative Net Change
earnings medical medical-devices
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand
by Zacks Equity Research
Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.
BSXPositive Net Change MASINegative Net Change WSTNegative Net Change GEHCNegative Net Change
earnings medical medical-devices
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
by Zacks Equity Research
Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.
BSXPositive Net Change FMSNegative Net Change WSTNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
by Zacks Equity Research
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change CLOVPositive Net Change
earnings medical medical-devices
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised
by Zacks Equity Research
Cencora posts strong Q3 results with earnings and revenues surpassing estimates; raises FY25 EPS guidance on robust U.S. segment growth.
BSXPositive Net Change CORPositive Net Change WSTNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Are Options Traders Betting on a Big Move in BrightSpring Health Services Stock?
by Zacks Equity Research
Investors need to pay close attention to BrightSpring Health Services stock based on the movements in the options market lately.
BTSGPositive Net Change
medical medical-devices
Tidewater (TDW)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
TDWPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls
by Zacks Equity Research
TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.
BSXPositive Net Change TECHNegative Net Change MEDPNegative Net Change WGSPositive Net Change
earnings medical medical-devices
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?
by Moumi Mondal
HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.
BDXPositive Net Change HOLXNegative Net Change GEHCNegative Net Change
medical medical-devices
Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?
by Zacks Equity Research
BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.
BDXPositive Net Change CAHPositive Net Change MCKNegative Net Change COOPositive Net Change
earnings medical medical-devices
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
by Zacks Equity Research
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
CAHPositive Net Change MCKNegative Net Change CRMDNegative Net Change SOLVPositive Net Change
medical medical-devices
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down
by Zacks Equity Research
Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.
BSXPositive Net Change WSTNegative Net Change HIMSNegative Net Change GEHCNegative Net Change
earnings medical medical-devices
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
by Zacks Equity Research
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
BSXPositive Net Change WSTNegative Net Change INSPNegative Net Change GEHCNegative Net Change
earnings medical medical-devices
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
by Moumi Mondal
CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.
AMZNPositive Net Change CVSPositive Net Change ELVPositive Net Change
medical medical-devices
Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?
by Zacks Equity Research
MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.
CAHPositive Net Change MCKNegative Net Change COOPositive Net Change CRMDNegative Net Change
medical medical-devices
ISRG's Ion Platform Sees Uptick in Utilization, Eyes Efficiency
by Indrajit Bandyopadhyay
Intuitive Surgical's Ion platform posted 52% procedure growth in Q2, but rising system utilization and workflow efficiency now drive its profitability focus.
SYKPositive Net Change ISRGPositive Net Change ZBHNegative Net Change
medical medical-devices
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results?
by Zacks Equity Research
COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness.
CAHPositive Net Change MCKNegative Net Change CORPositive Net Change CRMDNegative Net Change
medical medical-devices
AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
by Zacks Equity Research
Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change AVTRPositive Net Change
earnings medical medical-devices
Central Garden (CENT)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CENTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
by Zacks Equity Research
IDXX posts double-digit Q2 revenue growth, beats EPS estimates and lifts the full-year outlook as margins rise sharply.
BSXPositive Net Change IDXXNegative Net Change MEDPNegative Net Change WGSPositive Net Change
earnings medical medical-devices
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
by Zacks Equity Research
TECH eyes modest Q4 growth as strong reagent and instrumentation demand offsets NIH and tariff concerns.
TECHNegative Net Change CRMDNegative Net Change AMRXNegative Net Change GMABNegative Net Change
earnings medical medical-devices
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.
CAHPositive Net Change MCKNegative Net Change XRAYPositive Net Change CORPositive Net Change
medical medical-devices